Puma Biotechnology

Quarterly Financials

Values in thousands2025-12-312025-09-302025-06-302025-03-31
Revenue
$75,500
$54,475
$52,436
$46,007
Gross Profit
52,300
42,302
40,135
35,451
EBITDA
26,555
13,454
10,765
8,240
EBIT
18,200
10,732
8,002
5,444
Net Income
13,400
8,844
5,855
2,974
Net Change In Cash
75,500
54,475
52,436
46,007
Free Cash Flow
14,455
9,663
14,062
3,551
Cash
29,600
53,525
54,662
63,030
Basic Shares
51,521
50,929
50,144
49,906

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$228,371
$230,468
$235,637
$228,031
Gross Profit
170,214
166,064
172,955
172,938
EBITDA
53,342
48,076
47,523
21,889
EBIT
42,404
36,552
36,004
12,049
Net Income
31,111
30,278
21,591
2
Net Change In Cash
228,371
230,468
235,637
228,031
Cost of Revenue
3,500
Free Cash Flow
41,731
38,862
14,369
-22,827
Cash
29,635
69,219
84,585
76,201
Basic Shares
50,653
49,100
47,550
44,929

Earnings Calls

QuarterEPS
2026-03-31
$0
2025-12-31
$0.29
2025-09-30
$0.21
2025-06-30
$0.12